Far Infrared Radiation Treatment for Bipolar Condition

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by GAAD Medical Research Institute Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier:
NCT00573196
First received: December 12, 2007
Last updated: August 14, 2009
Last verified: August 2009

December 12, 2007
August 14, 2009
September 2006
February 2008   (final data collection date for primary outcome measure)
The primary end point is to determine the therapeutic effects of far infrared radiation on bipolar condition. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00573196 on ClinicalTrials.gov Archive Site
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Depression, Anxiety, Stress and Insomnia. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Far Infrared Radiation Treatment for Bipolar Condition
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Bipolar Condition

A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition

A 2000 study in the American Journal of Psychiatry reported that, "in those with bipolar, two major areas of the brain contain 30 percent more cells that send signals to other brain cells". This fact explains why famous people with the Bipolar condition like astronaut Buzz Aldrin, financier Robert Campeau, British Prime Minister Winston Churchill, composer Mozart, scientist Isaac Newton, physician Sigmund Freud and media giant & entrepreneur Ted Turner, excelled in life due to the additional brain power!

The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.

Interventional
Phase 1
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Bipolar Disorder
Radiation: Far infrared
Far infrared radiation (5μm to 15μm wavelength)
Experimental: 1
Intervention: Radiation: Far infrared
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
3
June 2008
February 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia

Exclusion Criteria:

  • Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00573196
GAAD-BPC-CTP1
Yes
Dr. Kwasi Donyina/Founder & President, GAAD Medical research Institute Inc.
GAAD Medical Research Institute Inc.
Not Provided
Principal Investigator: Kwasi Donyina, Ph.D. GAAD Medical Research Institute Inc.
Study Director: Ken Nedd, M.D. GAAD Medical Research Institute Inc.
GAAD Medical Research Institute Inc.
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP